These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36181491)

  • 1. Are Borderline Personality Disorder Features Differentially Related to Pre-Incarceration Alcohol, Cannabis, Cocaine, and Opioid Dependence Among People Recently Incarcerated in Jail?
    Loya JM; Tangney JP; Stuewig JB
    J Pers Disord; 2022 Oct; 36(5):623-640. PubMed ID: 36181491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline personality disorder features and drinking, cannabis, and prescription opioid motives: Differential associations across substance and sex.
    Vest NA; Murphy KT; Tragesser SL
    Addict Behav; 2018 Dec; 87():46-54. PubMed ID: 29945027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline personality disorder features and risk for prescription opioid use disorders.
    Tragesser SL; Jones RE; Robinson RJ; Stutler A; Stewart A
    J Pers Disord; 2013 Aug; 27(4):427-41. PubMed ID: 23718741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antisocial and borderline personality features in substance dependence among incarcerated females.
    Chapman AL; Cellucci T
    Addict Behav; 2007 Jun; 32(6):1131-45. PubMed ID: 16962249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coping motives mediate the relationship between borderline personality features and alcohol, cannabis, and prescription opioid use disorder symptomatology in a substance use disorder treatment sample.
    Vest NA; Tragesser S
    Personal Disord; 2020 May; 11(3):230-236. PubMed ID: 31815505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implications of borderline personality features for jail inmates' institutional misconduct and treatment-seeking.
    Yasmeen S; Tangney JP; Stuewig JB; Hocter C; Weimer L
    Personal Disord; 2022 Sep; 13(5):505-515. PubMed ID: 34780233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline Features and Prescription Opioid Misuse in a Substance Use Disorder Treatment Sample.
    Vest N; Tragesser S
    Subst Use Misuse; 2019; 54(1):166-175. PubMed ID: 30375912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms of anxiety, depression, and borderline personality in alcohol use disorder with and without comorbid substance use disorder.
    Howe LK; Fisher LR; Atkinson EA; Finn PR
    Alcohol; 2021 Feb; 90():19-25. PubMed ID: 33232791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity of Borderline Personality Disorder and Lifetime Substance Use Disorders in a Nationally Representative Sample.
    Carpenter RW; Wood PK; Trull TJ
    J Pers Disord; 2016 Jun; 30(3):336-50. PubMed ID: 25893556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does comorbid substance use disorder exacerbate borderline personality features? A comparison of borderline personality disorder individuals with vs. without current substance dependence.
    Lee HJ; Bagge CL; Schumacher JA; Coffey SF
    Personal Disord; 2010 Oct; 1(4):239-49. PubMed ID: 21116439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of borderline personality features to preincarceration HIV risk behaviors of jail inmates: Evidence for gender differences?
    Adams LM; Stuewig JB; Tangney JP
    Personal Disord; 2016 Jan; 7(1):40-9. PubMed ID: 26011575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age of onset of heaviest use of cannabis or alcohol in persons with severe opioid or cocaine use disorders.
    Butelman ER; Chen CY; Brown KG; Lake KJ; Kreek MJ
    Drug Alcohol Depend; 2021 Sep; 226():108834. PubMed ID: 34216857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borderline Personality Disorder Features and Risk for Prescription Opioid Misuse in a Chronic Pain Sample: Roles for Identity Disturbances and Impulsivity.
    Reynolds CJ; Vest N; Tragesser SL
    J Pers Disord; 2021 Apr; 35(2):270-287. PubMed ID: 31609188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol.
    Compton WM; Dawson DA; Goldstein RB; Grant BF
    Drug Alcohol Depend; 2013 Sep; 132(1-2):387-90. PubMed ID: 23642316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring associations between borderline personality disorder, crack/cocaine dependence, gender, and risky sexual behavior among substance-dependent inpatients.
    Tull MT; Gratz KL; Weiss NH
    Personal Disord; 2011 Jul; 2(3):209-19. PubMed ID: 22448767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motives for opioid use explain the relation between borderline personality disorder pathology and opioid use problems.
    Scamaldo KM; Tull MT; Gratz KL
    Psychiatry Res; 2021 Feb; 296():113609. PubMed ID: 33418458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of substance use in youth with borderline personality disorder.
    Scalzo F; Hulbert CA; Betts JK; Cotton SM; Chanen AM
    Personal Disord; 2018 Jul; 9(4):390-396. PubMed ID: 28627903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential prevalence of Adverse Childhood Experiences (ACEs) by gender and substance used in individuals with cannabis, cocaine, opioid, and tobacco use disorders.
    Martin EL; Neelon B; Brady KT; Guille C; Baker NL; Ramakrishnan V; Gray KM; Saladin ME; McRae-Clark AL
    Am J Drug Alcohol Abuse; 2023 Mar; 49(2):190-198. PubMed ID: 36881810
    [No Abstract]   [Full Text] [Related]  

  • 19. Borderline personality disorder symptoms in treatment-naïve actively drinking alcoholics.
    Fein G; Price M; Cardenas VA
    Alcohol; 2018 May; 68():81-89. PubMed ID: 29529507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance Use, Substance Use Disorders, and Co-Occurring Psychiatric Disorders in Recently Incarcerated Men: A Comparison with the General Population.
    Fovet T; Wathelet M; Benbouriche M; Benradia I; Roelandt JL; Thomas P; D'Hondt F; Rolland B
    Eur Addict Res; 2022; 28(5):368-376. PubMed ID: 36007504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.